VIVIFLUX -DHF: dihydrofolate
-THF: tetrahydrofolate
-5,10-METHF: 5,10-methylenetetrahydrofolate
-5-METHF: methyltetrahydrofolate
-MTHFR: methylenetetrahydrofolate reductase
-P5P: pyridoxal 5-phosphate
-R5P: riboflavin 5-phosphate
Folate is of fundamental importance for the conversion of homocysteine to methionine.
Methylenetetrahydrofolate reductase (MTHFR) is the rate-limiting enzyme in the methyl cycle that catalyses the only biochemical reaction producing 5-methyltetrahydrofolate (Quatrefolic), useful for reducing plasma homocysteine levels.
MTHFR C677T is a common MTHFR mutation with reduced catalytic activity, leading to high plasma homocysteine levels, a common risk factor for cardiovascular disorders. A recent meta-analysis (published in June 2017) observed that patients with the MTHFR C677T mutation have a 30% higher risk of developing ischaemic stroke.
Ingredients
Fish oil standardised in docosahexaenoic acid (DHA), extra virgin olive oil (Olea europaea L., fruit), food-grade gelatine (capsule ingredient), homotaurine, glazing agents: hydroxypropyl methylcellulose, shellac; anti-caking agents: silicon dioxide; antioxidant: DL-alpha-tocopherol; stabiliser: glycerol; Extracyan bilberry (Vaccinium myrtillus L., fruit) dry extract; colours: iron oxide, titanium dioxide; Quatrefolic [(6S)-5-methyltetrahydrofolic acid, glucosamine salt].
Directions for use
Take 1 capsule a day.
Pack size
20 liquid-filled capsules.
Code FBH0002